CT
Cambridge Trust Portfolio holdings
AUM
$2.64B
Turnover
15.41%
1-Year Est. Return
28.73%
This Fund
S&P 500
This Quarter
Est. Return
+5.39%
1 Year Est. Return
+28.73%
3 Year Est. Return
+42.93%
5 Year Est. Return
+123.28%
10 Year Est. Return
+319.24%
AUM
$2.1B
AUM Growth
-$138M
(-6.2%)
Cap. Flow
-$212M
Cap. Flow
% of AUM
-10.1%
Top 10 Holdings %
Top 10 Hldgs %
28.75%
Holding
831
New
19
Increased
68
Reduced
304
Closed
71
Avg Time Held
2.7
years
Top 10 Avg Time Held
2.9
years
Top 20 Avg Time Held
2.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$5.28M |
| 2 |
iShares MSCI Canada ETF
EWC
|
+$4.61M |
| 3 |
CVS Health
CVS
|
+$4.24M |
| 4 |
Aptiv
APTV
|
+$3.61M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$3.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$47.4M |
| 2 |
Union Pacific
UNP
|
+$31.8M |
| 3 |
UnitedHealth
UNH
|
+$21.1M |
| 4 |
Pioneer Natural Resource Co.
PXD
|
+$12.8M |
| 5 |
Visa
V
|
+$11.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.67% |
| 2 | Financials | 14.51% |
| 3 | Healthcare | 13.47% |
| 4 | Miscellaneous | 13.36% |
| 5 | Consumer Discretionary | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$5.01T
| $123M | 5.89% |
748,914
-25,053
| -3% | -$3.7M |
2013 Q2
39 quarters
|
|
2
Microsoft
MSFT
$3.96T
| $110M | 5.25% |
381,525
-9,537
| -2% | -$2.43M |
2013 Q2
39 quarters
|
|
3
ExxonMobil
XOM
$728B
| $54.2M | 2.58% |
494,155
-8,817
| -2% | -$975K |
2013 Q2
39 quarters
|
|
|
4
Alphabet (Google) Class A
GOOGL
$4.25T
| $49.1M | 2.34% |
473,788
+35,523
| +8% | +$3.41M |
2015 Q4
29 quarters
|
|
5
JPMorgan Chase
JPM
$890B
| $48.2M | 2.3% |
370,136
-7,215
| -2% | -$989K |
2013 Q2
39 quarters
|
|
|
6
Visa
V
$735B
| $48M | 2.29% |
213,022
-52,170
| -20% | -$11.6M |
2013 Q2
39 quarters
|
|
7
Procter & Gamble
PG
$364B
| $44.5M | 2.12% |
299,297
-40,631
| -12% | -$5.81M |
2013 Q2
39 quarters
|
|
|
8
UnitedHealth
UNH
$355B
| $42.6M | 2.03% |
90,051
-43,627
| -33% | -$21.1M |
2016 Q1
28 quarters
|
|
9
JPMorgan Equity Premium Income ETF
JEPI
$45.7B
| $42.3M | 2.02% |
774,370
+58,101
| +8% | +$3.15M |
2021 Q3
6 quarters
|
|
10
Johnson & Johnson
JNJ
$612B
| $40.4M | 1.93% |
260,640
-8,685
| -3% | -$1.4M |
2013 Q2
39 quarters
|
|
11
Berkshire Hathaway Class A
BRK.A
$1.13T
| $40M | 1.91% |
86
+7
| +9% | +$3.27M |
2013 Q2
39 quarters
|
|
12
iShares Core S&P 500 ETF
IVV
$887B
| $39M | 1.86% |
94,813
-4,620
| -5% | -$1.85M |
2014 Q3
34 quarters
|
|
13
Honeywell
HON
$65.8B
| $36.4M | 1.73% |
201,935
-1,471
| -0.7% | -$277K |
2015 Q4
29 quarters
|
|
14
Bristol-Myers Squibb
BMY
$121B
| $36.1M | 1.72% |
520,869
+44,103
| +9% | +$3.11M |
2013 Q2
39 quarters
|
|
15
Amazon
AMZN
$2.74T
| $35.6M | 1.7% |
344,265
+27,200
| +9% | +$2.63M |
2013 Q4
37 quarters
|
|
16
NextEra Energy
NEE
$163B
| $35M | 1.67% |
454,271
+30,118
| +7% | +$2.32M |
2013 Q2
39 quarters
|
|
17
McDonald's
MCD
$169B
| $33.8M | 1.61% |
120,722
-1,648
| -1% | -$442K |
2013 Q2
39 quarters
|
|
18
Broadcom
AVGO
$1.65T
| $33.4M | 1.59% |
519,900
+300
| +0.1% | +$18K |
2020 Q2
11 quarters
|
|
19
iShares Intermediate Government/Credit Bond ETF
GVI
$3.76B
| $33M | 1.58% |
316,134
-87,953
| -22% | -$9.1M |
2021 Q4
5 quarters
|
|
20
Cabot Corp
CBT
$3.88B
| $32.2M | 1.54% |
420,663
-9,000
| -2% | -$675K |
2013 Q2
39 quarters
|
|
21
Eaton
ETN
$159B
| $32.1M | 1.53% |
187,213
+881
| +0.5% | +$147K |
2019 Q1
16 quarters
|
|
22
American Express
AXP
$207B
| $30M | 1.43% |
181,599
-53,651
| -23% | -$8.9M |
2013 Q2
39 quarters
|
|
23
Novartis
NVS
$279B
| $28.6M | 1.36% |
310,514
-2,350
| -0.8% | -$205K |
2013 Q2
39 quarters
|
|
|
24
CVS Health
CVS
$116B
| $28.4M | 1.35% |
381,777
+50,524
| +15% | +$4.24M |
2013 Q2
39 quarters
|
|
25
Adobe
ADBE
$93.7B
| $26.6M | 1.27% |
69,046
-1,690
| -2% | -$601K |
2013 Q2
39 quarters
|
|
Similar funds
ZCM
CQS
WSTAM
CW
SCM
AFIMH
ICG
DA
Cambridge Trust's Q1 2023 Portfolio in Review
As of Q1 2023, Cambridge Trust held 831 positions worth $2.1B, down 6.2% from $2.24B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Cambridge Trust withdrew a net $212M in Q1 2023, closing 71 positions and reducing 304 holdings. Its most notable exit was Linde, an estimated $47.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Cambridge Trust opened a new position in State Street SPDR S&P 600 Small Cap Value ETF worth $343K.
- Cambridge Trust's largest Q1 2023 buy was State Street SPDR S&P 600 Small Cap Value ETF: 4,500 shares worth $343K.
- Cambridge Trust added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2023, an estimated $5.28M increase.
- Cambridge Trust's biggest Q1 2023 reduction was Union Pacific, cutting an estimated $31.8M.
- Cambridge Trust fully exited Linde in Q1 2023, selling an estimated $47.4M.
- Cambridge Trust's ten largest holdings make up 29% of its $2.1B portfolio in Q1 2023.
- Cambridge Trust opened 19 new positions and closed 71 in Q1 2023.
- Cambridge Trust's portfolio value fell 6.2% quarter-over-quarter to $2.1B.
Based on Cambridge Trust's 13F filing for Q1 2023, filed 12 May 2023.